Funded Tech Companies
Arrakis Therapeutics
Wondering who backed Arrakis Therapeutics? Pfizer Venture Investments, GV and WuXi AppTec joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Arrakis Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
830 Winter St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
The therapeutic potential of the human transcriptome, the set of all RNAs transcribed from DNA, remains largely unexplored. By harnessing new insights into RNA structure and dynamics, Arrakis is opening the transcriptome to therapy by small-molecule medicines to treat patients not cured by today's medicines.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/19/2019
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Gilman
Chief Scientific Officer
Russell Petter
Vice President
James Barsoum
Vice President
Gnanasambandam Kumaravel
VP - Bus. Development
Daniel Koerwer
VP - Operations
Heather Lounsbury
Company Investors
- Pfizer Venture Investments
- GV
- WuXi AppTec
- HBM Healthcare Investments
- Celgene (Russell Petter)
- Alexandria Venture Investments
- venBio (Richard Gaster)
- Omega Funds
- Canaan Partners (Colleen Cuffaro)
- Nextech Invest (Jakob Loven)
- Osage Partners (Matthew Cohen)
- Advent Life Sciences (Raj Parekh)
- Private Investors (Henri Termeer)
Browse more funded tech companies:
Share this article
About Our VC Funding Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs